Robert A. Mook

3.1k total citations · 1 hit paper
38 papers, 1.9k citations indexed

About

Robert A. Mook is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Robert A. Mook has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Robert A. Mook's work include Wnt/β-catenin signaling in development and cancer (8 papers), Cancer-related gene regulation (5 papers) and Microtubule and mitosis dynamics (4 papers). Robert A. Mook is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (8 papers), Cancer-related gene regulation (5 papers) and Microtubule and mitosis dynamics (4 papers). Robert A. Mook collaborates with scholars based in United States, Netherlands and China. Robert A. Mook's co-authors include Wei Chen, Jiangbo Wang, Richard T. Premont, H. Kim Lyerly, Xiu-Rong Ren, Larry S. Barak, John G. Lewis, Richard W. Wagner, Mark D. Matteucci and Kun Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Scientific Reports.

In The Last Decade

Robert A. Mook

38 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Niclosamide: Beyond an antihelminthic drug

2017 337 citations Wei Chen, Robert A. Mook et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Mook United States	24	1.2k	369	337	185	147	38	1.9k
Tomohiro Kawamoto Japan	24	1.1k 1.0×	301 0.8×	473 1.4×	232 1.3×	55 0.4×	61	1.9k
Ganesha Rai United States	26	1.3k 1.1×	175 0.5×	311 0.9×	108 0.6×	137 0.9×	90	2.2k
Mark J. Suto United States	30	1.5k 1.3×	531 1.4×	564 1.7×	147 0.8×	105 0.7×	88	2.6k
Réjean Ruel Canada	19	1.4k 1.2×	310 0.8×	469 1.4×	172 0.9×	141 1.0×	32	2.4k
M. Kyle Hadden United States	23	1.3k 1.1×	264 0.7×	182 0.5×	140 0.8×	133 0.9×	77	1.8k
Mahendra D. Chordia United States	26	769 0.7×	371 1.0×	471 1.4×	201 1.1×	65 0.4×	85	1.8k
Wynne Aherne United Kingdom	27	1.5k 1.3×	509 1.4×	161 0.5×	301 1.6×	73 0.5×	58	2.3k
H. Michael Petrassi United States	18	1.6k 1.4×	263 0.7×	304 0.9×	374 2.0×	59 0.4×	29	2.4k
Jinliang Yang China	29	1.3k 1.1×	566 1.5×	745 2.2×	185 1.0×	87 0.6×	109	2.7k
Maja Osmak Croatia	24	1.2k 1.0×	740 2.0×	376 1.1×	119 0.6×	118 0.8×	115	2.4k

Countries citing papers authored by Robert A. Mook

Since Specialization

Citations

This map shows the geographic impact of Robert A. Mook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Mook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Mook more than expected).

Fields of papers citing papers by Robert A. Mook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Mook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Mook. The network helps show where Robert A. Mook may publish in the future.

Co-authorship network of co-authors of Robert A. Mook

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Mook. A scholar is included among the top collaborators of Robert A. Mook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Mook. Robert A. Mook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valastyan, Julie S., Emilee E. Shine, Robert A. Mook, & Bonnie L. Bassler. (2025). Inhibitors of the PqsR Quorum-Sensing Receptor Reveal Differential Roles for PqsE and RhlI in Control of Phenazine Production. ACS Chemical Biology. 20(6). 1273–1287. 1 indexed citations

Wang, Jiangbo, Xiu-Rong Ren, Hailan Piao, et al.. (2019). Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy. Biochemical Journal. 476(3). 535–546. 57 indexed citations

Wang, Jiangbo, Robert A. Mook, Xiu-Rong Ren, et al.. (2018). Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth. Bioorganic & Medicinal Chemistry. 26(20). 5435–5442. 13 indexed citations

Mook, Robert A., Jiangbo Wang, Xiu-Rong Ren, et al.. (2018). Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype. Bioorganic & Medicinal Chemistry Letters. 29(2). 317–321. 9 indexed citations

Mook, Robert A., Xiu-Rong Ren, Jiangbo Wang, et al.. (2017). Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis. Bioorganic & Medicinal Chemistry. 25(6). 1804–1816. 20 indexed citations

Kanju, Patrick, Yong Chen, Whasil Lee, et al.. (2016). Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain. Scientific Reports. 6(1). 26894–26894. 60 indexed citations

Mook, Robert A., Jiangbo Wang, Xiu-Rong Ren, et al.. (2015). Structure–activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure. Bioorganic & Medicinal Chemistry. 23(17). 5829–5838. 58 indexed citations

Mook, Robert A., Minyong Chen, Jiuyi Lü, et al.. (2013). Small molecule modulators of Wnt/β-catenin signaling. Bioorganic & Medicinal Chemistry Letters. 23(7). 2187–2191. 23 indexed citations

Wang, Jiangbo, Jiuyi Lü, Robert A. Mook, et al.. (2012). The Insecticide Synergist Piperonyl Butoxide Inhibits Hedgehog Signaling: Assessing Chemical Risks. Toxicological Sciences. 128(2). 517–523. 28 indexed citations

10.

Wang, Jiangbo, Robert A. Mook, Jiuyi Lü, et al.. (2012). Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling. Bioorganic & Medicinal Chemistry. 20(22). 6751–6757. 23 indexed citations

11.

Wang, Jiangbo, Larry S. Barak, Robert A. Mook, & Wei Chen. (2011). Glucocorticoid Hedgehog Agonists in Neurogenesis. Vitamins and hormones. 87. 207–215. 15 indexed citations

12.

Stellwagen, John, George M. Adjabeng, Marc R. Arnone, et al.. (2011). Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup. Bioorganic & Medicinal Chemistry Letters. 21(15). 4436–4440. 22 indexed citations

13.

Emmitte, Kyle A., C. Webb Andrews, Ramesh Bambal, et al.. (2009). Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding. Bioorganic & Medicinal Chemistry Letters. 19(6). 1694–1697. 54 indexed citations

14.

Cheung, Mui, Kevin W. Kuntz, James M. Salovich, et al.. (2008). Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1. Bioorganic & Medicinal Chemistry Letters. 18(23). 6214–6217. 9 indexed citations

15.

Emmitte, Kyle A., C. Webb Andrews, Ronda G. Davis‐Ward, et al.. (2008). Discovery of thiophene inhibitors of polo-like kinase. Bioorganic & Medicinal Chemistry Letters. 19(3). 1018–1021. 33 indexed citations

16.

Petrov, Kimberly G., Yuemei Zhang, G. Stuart Cockerill, et al.. (2006). Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series. Bioorganic & Medicinal Chemistry Letters. 16(17). 4686–4691. 144 indexed citations

17.

Boros, Eric E., Eric C. Bigham, Robert A. Mook, et al.. (1999). Bis- and Mixed-Tetrahydroisoquinolinium Chlorofumarates: New Ultra-Short-Acting Nondepolarizing Neuromuscular Blockers. Journal of Medicinal Chemistry. 42(6). 1114–1114. 30 indexed citations

18.

Henke, Brad R., Steven G. Blanchard, Lisa M. Leesnitzer, et al.. (1999). Synthesis and biological activity of a novel series of indole-derived PPARγ agonists. Bioorganic & Medicinal Chemistry Letters. 9(23). 3329–3334. 29 indexed citations

19.

Frye, Stephen V., Curt D. Haffner, Patrick Maloney, et al.. (1994). 6-Azasteroids: Structure-Activity Relationships for Inhibition of Type 1 and 2 Human 5.alpha.-Reductase and Human Adrenal 3.beta.-Hydroxy-.DELTA.5-steroid Dehydrogenase/3-Keto-.DELTA.5-steroid Isomerase. Journal of Medicinal Chemistry. 37(15). 2352–2360. 49 indexed citations

20.

Frye, Stephen V., Curt D. Haffner, Patrick Maloney, et al.. (1993). 6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5.alpha.-reductase. Journal of Medicinal Chemistry. 36(26). 4313–4315. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact